TSL on track, eases into sales model
This article was originally published in Clinica
UK human tissue repair producer TSL (Aldershot, Hampshire) saw gratifying development of its four-channel business structure in the first half of 2005, with first sales being made to Zimmer. TSL shipped $200,000-worth of sales of porcine dermis products to its new US orthopaedic partner, which began marketing Zimmer Collagen Patch for rotator cuff repairs in July.
You may also be interested in...
More patent-related turbulence appears ahead for Novartis’s sacubitril/valsartan combination in India, with Torrent emerging as the new challenger. The companies are engaged in a legal battle and the Indian firm is also seeking a revocation of the patent on the star heart failure treatment.
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Among the largest gaps in safety data is non-clinical research on CBD use's effect on developing fetus and adolescent brain, in utero/lactational exposure, reproductive toxicity and the potential for a latency period before toxicity, says FDA neuroscientist Andrew Shen.